Literature DB >> 6579552

Mechanisms of hydroxylation by cytochrome P-450: metabolism of monohalobenzenes by phenobarbital-induced microsomes.

L T Burka, T M Plucinski, T L Macdonald.   

Abstract

The monohydroxylation of halobenzenes by phenobarbital-induced rat liver microsomes was studied. The p-halophenol was found to be the major metabolite from all four halobenzenes; o-halophenol formation decreased as the halogen atom size increased. Vmax for total hydroxylation (ortho and para products) correlated well with the sigma + Hammett constant with a negative rho value. This implies a positively charged intermediate in the rate-determining step. Vmax for either ortho or para hydroxylation alone did not correlate with a Hammett constant, implying that the product-determining step occurs after the rate-determining step. Rate-determining formation of a radical cation intermediate is postulated to explain this data.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6579552      PMCID: PMC391234          DOI: 10.1073/pnas.80.21.6680

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 2.  Cytochrome P450 and biological hydroxylation reactions.

Authors:  V Ullrich
Journal:  Top Curr Chem       Date:  1979

3.  Metabolism of vinyl chloride: destruction of the heme of highly purified liver Microsomal cytochrome P-450 by a metabolite.

Authors:  F P Guengerich; T W Strickland
Journal:  Mol Pharmacol       Date:  1977-11       Impact factor: 4.436

4.  Role of detoxifying enzymes in bromobenzene-induced liver necrosis.

Authors:  N Zampaglione; D J Jollow; J R Mitchell; B Stripp; M Hamrick; J R Gillette
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

5.  Metobolism of chlorobenzene with hepatic microsomes and solubilized cytochrome P-450 systems.

Authors:  H G Selander; D M Jerina; J W Daly
Journal:  Arch Biochem Biophys       Date:  1975-05       Impact factor: 4.013

6.  Secondary deuterium isotope effects on olefin epoxidation by cytochrome P-450.

Authors:  R P Hanzlik; G O Shearer
Journal:  Biochem Pharmacol       Date:  1978-05-15       Impact factor: 5.858

7.  Metabolic activation and detoxification of bromobenzene leading to cytotoxicity.

Authors:  S S Lau; G D Abrams; V G Zannoni
Journal:  J Pharmacol Exp Ther       Date:  1980-09       Impact factor: 4.030

8.  Hepatic microsomal epoxidation of bromobenzene to phenols and its toxicological implication.

Authors:  S S Lau; V G Zannoni
Journal:  Toxicol Appl Pharmacol       Date:  1979-09-15       Impact factor: 4.219

9.  Aliphatic hydroxylation by highly purified liver microsomal cytochrome P-450. Evidence for a carbon radical intermediate.

Authors:  J T Groves; G A McClusky
Journal:  Biochem Biophys Res Commun       Date:  1978-03-15       Impact factor: 3.575

10.  Deuterium isotope effects during formation of phenols by hepatic monoxygenases. Evidence for an alternative to arene oxide pathway.

Authors:  J E Tomaszewski; D M Jerina; J W Daly
Journal:  Biochemistry       Date:  1975-05-06       Impact factor: 3.162

View more
  5 in total

1.  Transformations of Aromatic Compounds by Nitrosomonas europaea.

Authors:  W K Keener; D J Arp
Journal:  Appl Environ Microbiol       Date:  1994-06       Impact factor: 4.792

2.  Evidence for Chlorine Migration during Oxidation of 2-Chlorobiphenyl by a Type II Methanotroph.

Authors:  P Adriaens
Journal:  Appl Environ Microbiol       Date:  1994-05       Impact factor: 4.792

Review 3.  Synthetic Fe/Cu Complexes: Toward Understanding Heme-Copper Oxidase Structure and Function.

Authors:  Suzanne M Adam; Gayan B Wijeratne; Patrick J Rogler; Daniel E Diaz; David A Quist; Jeffrey J Liu; Kenneth D Karlin
Journal:  Chem Rev       Date:  2018-10-29       Impact factor: 60.622

4.  Will 1,2-dihydro-1,2-azaborine-based drugs resist metabolism by cytochrome P450 compound I?

Authors:  Pedro J Silva
Journal:  PeerJ       Date:  2016-07-28       Impact factor: 2.984

5.  Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugates.

Authors:  David Teze; Dumitru-Claudiu Sergentu; Valentina Kalichuk; Jacques Barbet; David Deniaud; Nicolas Galland; Rémi Maurice; Gilles Montavon
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.